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ABSTRACT Mapping the brain centers that mediate the sensory-perceptual processing of visceral afferent
signals arising from the body (i.e., interoception) is useful both for characterizing normal brain activity and
for understanding clinical disorders related to abnormal processing of visceral sensation. Here, we report a
novel closed-system, electrohydrostatically driven master–slave device that was designed and constructed for
delivering controlled fluidic stimulations of visceral organs and inner cavities of the human body within the
confines of a 3T magnetic resonance imaging (MRI) scanner. The design concept and performance of the
device in the MRI environment are described. In addition, the device was applied during a functional MRI
(fMRI) investigation of visceral stimulation related to detrusor distention in two representative subjects to
verify its feasibility in humans. System evaluation tests demonstrate that the device is MR-compatible with
negligible impact on imaging quality [static signal-to-noise ratio (SNR) loss <2.5% and temporal SNR loss
<3.5%], and has an accuracy of 99.68% for flow rate and 99.27% for volume delivery. A precise synchro-
nization of the stimulus delivery with fMRI slice acquisition was achieved by programming the proposed
device to detect the 5 V transistor–transistor logic (TTL) trigger signals generated by the MRI scanner. The
fMRI data analysis using the general linear model analysis with the standard hemodynamic response function
showed increased activations in the network of brain regions that included the insula, anterior and mid-
cingulate and lateral prefrontal cortices, and thalamus in response to increased distension pressure on viscera.
The translation from manually operated devices to an MR-compatible and MR-synchronized device under
automatic control represents a useful innovation for clinical neuroimaging studies of human interoception.
INDEX TERMS MR-compatible sensors and actuators, fMRI, electrohydrostatic actuation, automation,
visceral afferent processing.
I. INTRODUCTION
The development ofmodern neuroimaging techniques, in par-
ticular, blood-oxygen-level-dependent (BOLD) functional
magnetic resonance imaging (fMRI) made it possible to
study the brain networks that subserve sensory process-
ing and related perceptual phenomena. As the scientific
understanding of the neural correlates of the exterocep-
tive sensory modalities such as vision, audition, olfac-
tion, gustation (taste), and somatosensation (e.g., cutaneous
mechano-reception and proprioception) is increasing over
time, the mechanisms underlying cerebral modulations
of the interoceptive systems [1] have remained under-
represented in the existing fMRI literature (except per-
haps in the area of human nociception [2]). In recent
years, however, there has been a renaissance of interest in
studying the human interoceptive brain networks, in par-
ticular for the gastrointestinal and the urogenital systems,
as the significance of the brain-viscera interactions in health
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and their disruptions in various functional visceral diseases,
such as gastroesophageal reflux, dyspepsia, irritable bowel
syndrome, overactive bladder, and incontinence have become
more evident [3]–[6].
Interoception is the ability to sense the psycho-
physiological condition of the body [1] such as the sensations
that arise from the viscera and internal milieu including
pain, organ pressure, and distention [7]–[9]. Neuroanatom-
ical evidence suggests that the interoceptive-rich Aδ and C
primary afferents enter the spinal cord through the lamina I
of the dorsal horn of the spinal cord, and ascend in the
contralateral lateral spinothalamic tract [10]. Since the major
cortical targets of the thalamic projections from the lamina I
neurons are the insula and the anterior cingulate cortex, these
two brain regions are proposed to play an important role
in processing visceral sensations [1], [11] with additional
regions such as the prefrontal cortex are shown to become
progressively involved as subjective awareness of feeling and
volitional control of related actions emerges [12]–[15].
Visceral sensations that resemble real life situations are
challenging to implement inMRI in part due to the difficulties
involved in selectively stimulating a specific visceral organ in
the MRI environment. The limited space within the magnet
bore, and the posture of a subject lying on the scanner table
(e.g., supine position) make it difficult to deliver visceral
stimulations. The afferent signals often do not produce any
obvious subjective experiences, consequently making it hard
to rely on subjective assessment of interoceptive stimulation.
Interoceptive awareness varies from diffused, vague feelings
to distinctly sensed and localized perceptions that are pro-
jected to specific parts of the body schema [16]. Sensations
from non-visceral sources can also mask visceral sensations
by sensory gating and convergence mechanisms [17].
Despite these challenges, some promising work has been
recently conducted to investigate interoceptive phenomena,
such as the sensations that accompany digestion and elimi-
nation, in the confines of the magnet. In these fMRI stud-
ies, similar to the so-called interventional MRI techniques,
a catheter or a tube was introduced into a body cavity or a
visceral organ such as the esophagus, stomach and bladder,
for administering various fluid substances to directly stimu-
late the chemo- or mechanoreceptors in the intended organ
and elicit associated visceral sensations. Lassman et al. [18]
inserted a fine-bore orogastric tube in participants’ stomach
and manually infused ingested lipid (dodecanoic acid) or
sterile saline (control) into the stomach during fMRI for
studying brain regions responding to ingested lipid and the
role of the intestinal peptide cholecystokinin in mediating
gut–brain signaling. Similarly, Van Oudenhove et al. [19]
performed manual intragastric infusion of fatty acid solution
or saline during fMRI while participants underwent neutral or
sad emotion induction to investigate the interaction between
nutrient-induced gut-brain signaling and sad emotion.
To study regional brain activations in response to contact of
esophageal mucosa with acid, Kern et al. [20] administered
intraesophageal infusion of 0.1NHCl and compared the fMRI
BOLD responses with those of saline infusion and balloon
distention. To elucidate processing of urgency sensations,
Mehnert et al. [21] catheterized subjects transurethrally and
performed manual intravesical infusion of saline.
However, for an accurate interpretation of brain activity
during visceral sensation in fMRI, it is essential to have
complete control over the temporospatial properties of the
visceral stimuli. Methodologically, manual administration of
the fluid substances during a scan can be challenging espe-
cially because of an inadvertent variability of manual per-
formance in task-related requirements such as timing, flow
rate, and volumetric accuracy of infusion. This can be a
major concern if different infusion volumes, flow rates or
sequences of visceral infusion and drainage within an fMRI
paradigm are envisioned, consequently requiring multiple
manual adjustments of the flow rates during the course of
a scan. Reoccurring breaks may not only create discomfort
and distraction to a subject within the MRI scanner, but can
also introduce artifacts and temporal inconsistencies in the
acquired images. Due to the delayed time course of the BOLD
fMRI signal compared to the neuronal activity [22], exact
timing and precise stimulation intensity is necessary.
The aims of this study were (i) to design a new fluidic-
based, MR-synchronized device that can deliver precise vol-
umes of saline or biological fluids at a precise time to an
internal organ inside a conventional 3T MRI scanner with-
out interfering with imaging data acquisition, and (ii) to
assess feasibility of using such a device during human fMRI.
To implement fMRI studies using a mechatronic device,
safety aspects and technical challenges must be overcome
that are associated with introducing any new device to the
fMRI environment [23]–[25]. A device is considered to be
MR-compatible if it satisfies the following criteria: 1) it
does not pose a health and safety hazard, 2) its introduction
into the MRI environment does not affect the image quality,
and 3) its operation remains unaltered when used inside the
MRI environment [24], [25]. We addressed these challenges
by designing a robust system, and subsequently tested its
MR-compatibility and utility in a representative human
fMRI experiment.
II. MATERIAL AND METHODS
A. SYSTEM ARCHITECTURE
A computer-controlled linear slide (Fig. 1a), comprising a
bipolar stepper motor and a moving platform joined to a
stationary base by a linear bearing system, is connected to
a bi-directional pump that causes fluid flow and pressure
changes in a hydraulic actuator. The pressurized hydraulic
fluid transmits the energy through a closed-loop, flexible
plastic pipeline to a slave cylinder inside the 3T MRI scanner
room. In this closed-system configuration, positive or neg-
ative pressures in the slave cylinder result in a controllable
movement of the slave piston, thus mirroring motions of the
master cylinder outside the electromagnetic shield of the 3T
MRI scanner room. A mechanical interface (Figs. 1b and 1c)
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FIGURE 1. MR-compatible fluidic visceral stimulation device hardware. The device consists of: 1) AC power plug for stepper-motor-controlled linear
slide, 2) motorized linear slide, which provides motion control via RS232 interface, 3) moving platform of the motorized linear slide and a right angle
bracket that secures piston rod attachment to the moving platform, 4) master cylinder, 5) closed-loop 10 m flexible PVC tubing as a hydrostatic
transmission line, 6) slave cylinder, 7) mechanical interface interconnecting coaxial slave piston to the syringe, 8) single-use syringe, 9) single-use
catheter or tube, 10) MR-compatible fiber optic sensing unit, 11) fiber optic sensing unit’s circuit board, 12) auxiliary PC where the operational control
software runs, 13) MRI console PC; (a) Close-up view of the motorized linear slide and master cylinder rigidly attached to the moving plate of a linear
slide by a 90-degree angle bracket; (b) The slave module containing the mechanical interface that interconnects the slave cylinder (left) to the infusion
unit (right) including a 100 mL disposable syringe and a silicon catheter. The fiber optic sensing unit attaches to the mechanical interface that is placed
inside the MRI scanner room as part of the slave module (the black cable in the picture is the 10-m fiber optic cable); (c) Another view of the slave
module with an orogastric tube attached to a disposable 100 mL syringe. The disposable syringe and tube can be easily assembled (top) and
disassembled (bottom) from the mechanical interface of slave module; (d) The auxiliary PC displaying the operational GUI. The box next to the PC is
circuit board for the fiber optic sensing unit.
allows coupling of the slave piston and a syringe so that upon
actuation of the device, the plunger in the syringe barrel is
inserted or withdrawn in accordance with the motion of the
slave piston, thus creating a dispensing or aspirating effect
to infuse or drain fluid from the subject’s visceral organ or
internal body cavity through a connected catheter or tube.
Most notably, the closed-system configuration means that
the hydraulic fluid that is contained inside the master-slave
system is separated from the fluid (e.g., saline or biological
fluids) that is directly infused into or drained out of the
subject’s body.
The key components of the closed-system device
(Fig. 1, center) include a pair of double-action hydraulic mas-
ter and slave pistons, each encased in a plastic chamber made
from modified 140 mL polyethylene/polypropylene Mono-
ject piston syringes (Covidien-Kendall, USA), 10 m flexible
PVC tubing with an inside diameter of 6 mm and wall thick-
ness of 1.5mm (Emil LuxGmbH&Co., Germany), a custom-
madeMR-compatible fiber optic sensor unit (detailed below),
a motorized linear slide (model T-LSR 150B) with 150 mm
travel and 0.5 µm resolution (Zaber Technologies Inc.,
Canada), a 90 degree angle bracket (AB90-M, Zaber Tech-
nologies Inc., Canada), which rigidly secures the master
piston rod to the moving plate of the slider, and an infu-
sion unit. The infusion unit includes a sterile single-use
100 mL medical-grade polyethylene/polypropylene syringe
(Omnifix, B Braun Melsungen AG, Germany) that can be
attached to a single-use polyurethane naso/orogastric feeding
tube (CH/FR 15, Freka R©Tube, Fresenius Kabi Ltd, UK) or
a sterile single-use silicone catheter (CH/FR 14, UROMED
Kurt Drews GmbH, Germany). The mechanical interface
TABLE 1. Specifications of the Fiber Optic Sensor
that interconnects two coaxial pistons by their plunger shafts
was machined from plexiglass and polyacetal copolymer
(Angst+Pfister, Switzerland).
The MR-compatible fiber optic sensing unit (indicated by
an arrow and the label 10 in Fig. 1, center) comprises a
reflective-type intensity modulated fiber optic sensor with
an analogue voltage-output photodiode (FWDK 10U84Y0,
Baumer Electric, Switzerland), a 10 m plastic sheathed, flex-
ible fiber optic cable with two optical fibers as transceivers
(FUE 999C1004, Baumer Electric, Switzerland), and a high-
quality glossy photo paper on which a continuous gray spec-
trum is printed and attached to a thin polyacetal copolymer
rod with 1 cm in diameter. The technical specifications of
the fiber optic sensor are summarized in Table 1. The sensor
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FIGURE 2. MR-compatible fiber optic sensing unit for the slave module (a) Sensing principle; (b) Relationship between the percent
output voltage generated by the fiber optic sensor and the discharged volume from the 100 mL syringe in the slave module. Error bars
indicate standard errors of the mean of three measurements.
is attached to the mechanical interface placed inside the
3TMRI scanner room using a rubber gasket and brass screws.
The sensing principle of this unit is illustrated in Fig. 2a.
As the mechanical interface moves, the rod holding the gray
spectrum moves accordingly in front of the stationary fiber
optic sensor. Changes in the optical reflection properties
produce differential output signals from the sensor (Fig. 2b),
and quantification of parameters including relative linear
displacement and velocity of the slave module are calcu-
lated from optical sensor’s output voltage. We used a 15V
AC-to-DC converter (PM10-15, Mean Well Inc., USA) to
provide required power for the optical sensor, and included
a 12-bit multifunction USB data acquisition card (DAQ
USB-6008, National Instruments) to sample signals from
the sensor during the operation of the device (Fig. 3).
The interface card also detects the 5 V transistor-transistor
logic (TTL) trigger signals generated by MRI scan-
ner at each radiofrequency excitation pulse to synchro-
nize the device movements with image acquisition during
fMRI.
FIGURE 3. Slave module optical sensing unit circuit board. The board
includes a power supply, a data acquisition card, and an optical amplifier
placed outside the MRI scanner room in the control booth to prevent
image artifacts and other issues related to the non-MR-compatibility of
the circuit board components.
The safety criterion requires that the interactions between
a device and MRI scanner should not cause health and safety
hazards [23]–[25]. Primary interactions between a device and
the MRI scanner include the magnetically induced forces
and torques, radiofrequency-induced heating, and induction
of voltages [26]. For optimum safety and MR-compatibility,
these interactions must be properly controlled [27]. In addi-
tion, the device should guarantee that the fluid, which is
infused into or drained out of a subject’s visceral organ or
body cavity, does not leak or become contaminated during its
operation, because if this happens, it can expose the subject
to serious biohazards, increase the risk of residual cross-
contamination between successive subjects, and possibly
hinder the function of the device. The problem of residual
cross-contamination between subjects is a serious concern
due to the many known diseases that can be communicated
by the transfer of infected body fluids between subjects espe-
cially in clinical settings. Therefore, any section of the device
coming into direct contact with the subject’s internal cavity
should be sterile, and securely mountable to the system to
prevent any possible contamination or leakage of fluid. The
use of a disposable, single-use catheter or tube with a single-
use plastic syringe in the infusion unit of the device (the only
section of the device that comes into a direct contact with
a subject’s body) guarantees sterile conditions and good
clinical practice during operation. Additionally, distilled
water was used as working fluid inside the closed-system
instead of conventional petroleum or mineral oil to maintain
a clean, non-polluting system inside the MRI environment.
The control of the flow rate is accomplished by the control
of the position and speed of the stepper-motor-controlled
linear slide through feedback signals from the slave module
fiber optic sensing unit. A block diagram representation of
the operational control software developed for this device
is shown in Fig. 4. We leveraged the build-in motion con-
troller provided by Zaber Technologies, and programmed a
central operational controller interface in C++ using Visual
Studio 2010 (Microsoft, USA) running under the Windows
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FIGURE 4. Block diagram representation of the MR-compatible fluidic
visceral stimulation device operational control software. The
custom-designed software includes an input unit that receives a
user-defined fMRI paradigm sequence, a TTL signal detection unit for
starting the operation and synchronizing the system function with the
acquisition of functional volumes by the MRI scanner, a motor motion
sensor for sensing the actual motor speed and traveling distance, an
optical sensing unit for measuring the traveling distance and velocity of
the slave module, a memory unit for storing the system variables as logs,
and a GUI for displaying the system status to a user during fMRI.
operating system with a graphical user interface (GUI) for
user input. The custom-made software allows users to define
system parameters such as flow rate, and delivery volume.
The GUI consists of an easy-to-use menu for various actions
such as: choosing a specific fMRI paradigm, synchroniz-
ing the stimulation process with the acquisition of func-
tional volumes through detection of the TTL pulses from the
MRI scanner, controlling the stepper-motor-controlled linear
slide, monitoring displacement of slave pieces for output
flow rate accuracy, connecting to external devices such as a
response box, and storing the operation variables as a log file
for future reference.
B. DEVICE TESTING PROCEDURE
We performed a series of MR-compatibility tests, and eval-
uated the system performance in terms of flow rate and
volume delivery accuracy at the MRI center of the University
Hospital Zurich on a 3T whole-body MRI scanner (Ingenia,
Philips Medical Systems) with a standard 15-channel head
coil array. ForMR-compatibility tests, the imaging object was
a 3,000 mL cylindrical liquid phantom (Philips P/N
452213081924, diameter: 13.5 cm, height: 30 cm) contain-
ing 1,000 mL of demineralized water with 770 mg CuSO4
5H2O, 2,000 mg NaCl, 1 mL arquad (1% solution), and
0.15mLH2SO4 (0.1M solution). Functional images sensitive
to BOLD contrast were acquired in an ascending fashion
with 34 axial slices (each 3.0 mm thick, 1.0 mm inter-slice
gap) using a T2∗-weighted, single-shot, field echo, echo-
planar imaging (EPI) sequence (TE/TR = 30/2000 ms, flip
angle = 80◦, field of view = 240 mm × 240 mm, image
matrix = 96 × 96). The following conditions were tested on
a phantom while an MR volume of thirty-one dynamic slices
were acquired for each condition: (a) without the presence
of the system (more specifically the slave module) in the
MRI scanner room (i.e., phantom only; ‘‘Baseline’’), (b) with
the slave module installed in the 3T MRI scanner room but
powered off (‘‘Installed’’), (c) with the installed slave module
in the 3T MRI scanner room with the active components
powered on but not actuated (‘‘Powered’’), and (d) with the
installed slave module in the 3T MRI scanner room with the
active components powered on and actuated (‘‘Actuated’’).
When present, the installed slave module was placed next to
the 3T MRI scanner bore on the scanner table about 40 cm
away from the base of the phantom. This distance is the typi-
cal working distance for visceral stimulation of the gastroin-
testinal tract (e.g., stomach, esophagus) but closer than the
typical working distance of 50–60 cm for stimulating the uro-
genital system (e.g., bladder).We chose the 40-cm distance to
emphasize the effects of the slave module’s presence near the
phantom. The phantom was placed in the head coil and was
kept immobilized with foam pads during the scan. In each
test iteration, in addition to the EPI imaging protocol, we also
acquired anatomical images (3D T1-FFE [Fast Field Echo],
3.1 ms TE, 6.9 ms TR, 8◦ flip angle, 256 mm × 256 mm
field of view, 256× 256 matrix, voxel size = 1 mm × 1 mm
× 1 mm, 180 slices), and magnetic field map (3D T1-FFE,
2.3 ms TE1, 4.6 ms TE2, 20 ms TR, 10◦ flip angle,
240 mm × 240 mm field of view, 80 × 80 matrix, 3.0 mm
thickness, 50 slices) for added image quality analysis. The
ambient room air temperature was held constant at around
25◦C during the entire test period.
Both quantitative and qualitative methods were used to
evaluate the MR-compatibility of the fluidic visceral stimu-
lation device. For qualitative assessments, we evaluated the
static signal-to-noise ratio (SNR), the time variant (temporal)
signal-to-noise ratio (tSNR) and image homogeneity (uni-
formity) as a measure of spatial image quality, image time
course stability, and spatial homogeneity of the MR image,
respectively. The static SNR values for each condition were
calculated for anatomical and functional images according to
the signal-background method by dividing the mean signal
intensity over the standard deviation of background signal
noise corrected with the Rayleigh distribution factor [28]. For
an acquired MR image, the signal intensity was calculated
by taking the mean voxel intensity value in a homogenous
circular region of interest (ROI) within the phantom,while the
noise was computed from the background air voxel by defin-
ing four smaller ROIs outside the phantom (free of phase-
encode ghosting artifacts). The tSNR for each condition was
calculated voxelwise only for functional images as the ratio
between the mean signal intensity of the time series xi and its
temporal standard deviation as in (1):
tSNR = µ√
1/N
N∑
i=1
(xi − µ)2
(1)
where N is the number of time points [29]. Although the
static SNR is typically used to compare imaging hardware
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or acquisition methods [30], the tSNR may be a better proxy
for fMRI performance because the static SNR reflects only
static noise or single MR image signal strength over the noise
present in the absence of signal [29]. The functional image
homogeneity was calculated using (2) as proposed by the
American Association of Physicists in Medicine (AAPM)
protocol [31]:
Homogeneity = 100%×
(
1− Max −Min
Max +Min
)
(2)
where Max and Min are the maximum and minimum image
signal intensities of the ROI inside the imaging phantom.
To check whether the static SNR and tSNRwere significantly
changed in any condition, one-sample t-test was performed
using R statistical software (version 3.1.0, http://www.r-
project.org) where p < 0.05 was considered to be statistically
significant.
For the qualitative evaluation, in addition to visually
inspecting all MR images (anatomical, functional, and field
maps) for the presence of an artifact, we performed image
quality checks by image subtraction method in the following
manner: the binary image data of acquisitions from each
condition were subtracted pixel by pixel from the baseline
condition (i.e., phantom only, no device), resulting in differ-
ence images. The slice positioning was the same, and every
EPI slice was analyzed separately for each condition. Image
analysis was performed using an in-house-written MATLAB
script. Furthermore, the magnetically induced displacement
force was measured indirectly via a deflection angle between
the magnetically induced force of a device and its force due
to gravity as described in [32].
To evaluate the performance quality of the device,
we measured the flow rate and volume delivery accuracy
outside the 3TMRI scanner roomwith a Cubemass DCI Cori-
olis flow meter (Endress + Hauser, Switzerland, instrument
errors of 0.1%). Five flow rates from 100 to 500 mL/min
in 100 mL/min increments were used to test the system per-
formance. For each flow rate, we performed three repetitive
infusion and drainage cycles of 100 mL of sterile solution
of 0.9% NaCl (B Braun Melsungen AG, Germany) at room
temperature (∼25◦C). Next, we repeated the same exper-
iment inside the 3T MRI scanner room during functional
imaging scanning and also while the scanner was quiescent.
To evaluate the performance of the device in the MRI envi-
ronment, a custom-designed apparatus was used to record the
infusion and drainage rates and transferred volumes (Fig. 5).
A silicone catheter with a conical Nelaton tip (CH/FR 14,
UROMED Kurt Drews GmbH, Germany) was first attached
to a 100 mL polyethylene/polypropylene syringe (Omnifix,
B Braun Melsungen AG, Germany) filled with 100 mL
sterile solution of 0.9% NaCl (B Braun Melsungen AG,
Germany) at room temperature. The syringe was attached to
the slave cylinder through themechanical interface. The slave
module was placed on the MRI scanner table about 40 cm
away from the phantom base. The distal end of the catheter
was inserted into an empty 120 mL transparent plastic
FIGURE 5. Experimental setup for evaluating the system performance
inside 3 Tesla MRI scanner. A silicone catheter was attached to a 100 mL
syringe connected to the slave cylinder through the mechanical interface
and placed on the scanner table about 40 cm away from the base of the
phantom. The distal end of the catheter was inserted inside an empty PET
container, where an optical sensor was carefully positioned on top of it.
A floating styrofoam ball with a thin plastic rod holding a printed gray
spectrum line was placed inside. As the container filled, the styrofoam
ball remained on the water surface while the spectrum moved upward
resulting in change in voltage output from the optical sensor, which was
recorded and saved on a computer during the testing.
(polyethylene terephthalate; PET) container, and the dis-
pensed saline was collected in this container. A similar optical
sensor to the one that was used in the slave displacement sen-
sor, but with a slightly larger sensing range (FUE 500C1003,
Baumer Electric, Switzerland) was carefully positioned at
the top of the plastic collecting bottle as shown in Fig. 5.
A floating styrofoam ball was placed at the bottom of the
empty plastic container with a thin polyacetal copolymer rod
inserted into the center of the ball. A high-quality glossy
photo paper with a printed continuous spectrum of gray was
glued to the rod and placed facing the fiber optic sensor.
As the container filled, the styrofoam ball remained on the
water surfacewhile the rodmoved upward resulting in change
in the voltage output from the optical sensor. Data from
both optical sensors (i.e., optical displacement sensor and
optical sensor tracking the ball) were logged onto a desktop
computer and processed using a custom-developed software
program (LabVIEW, National Instruments). During the test,
the volume of the infusate and the linear displacement of
the slave module were recorded continuously as a function
of the respective optical sensor signal output and saved on
the computer. At the end of each test, the infusion rate was
calculated by converting the output voltage to discharged
volume and subtracting the volume at a given time (Vt) from
that obtained at the next time point (V[t+1t]) as in (3):
Q = Vt − V(t+1t)
1t
(3)
where t is the time in seconds. The values were multiplied
by 60 to obtain flow rates in ml/min. Data were reported as
mean±SD. The accuracy of each parameter was calculated as
the difference between the set value andmeasuredmean value
in percent, while the precision was computed as the standard
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FIGURE 6. Scanning protocol and fMRI task sequence. The fMRI measurements started with initial 10-second subject rating followed by
20-second rest. Subsequently 90 mL room temperature saline was repeatedly infused and drained intravesically by the MR-compatible
fluidic visceral stimulation device at the rate of 300 mL/min during fMRI. Eight blocks were performed with each block consisting of
intravesical infusion (90 mL saline in 15 s then pause 15 s for a total time of 30 s), subject rating after intravesical infusion (10 s);
rest (20 s), intravesical drainage (90 mL in 15 s then pause 15 s for a total time of 30 s), subject rating after intravesical drainage (10 s),
and rest (20 s).
deviation of these differences. The performance of the system
was also tested with an orogastric feeding tube (Freka R©Tube,
CH/FR 15, Fresenius Kabi Ltd, Warrington, UK) following
the same experimental procedures and set up described above
but only for infusion given that feeding tubes are generally
used for visceral infusion in MRI.
C. HUMAN fMRI EXPERIMENT
Two right-handed [33] healthy subjects (both females,
ages 21 and 47 years), with no history of neurological disor-
ders, and no symptoms suggestive of urological dysfunction
participated in return for payment. All subjects provided writ-
ten informed consent to participate according to a protocol
approved by the ethics committee of the canton of Zurich
and in complete accordance with the Helsinki Declaration
(http://www.wma.net/en/30publications/10policies/b3).
The visceral stimulation consisted of infusing then drain-
ing the bladder as a representative internal organ in a block
design paradigm (Fig. 6) with 90 mL room-temperature
sterile solution of 0.9% NaCl (B Braun Melsungen AG,
Germany) at a rate of 300 mL/min followed by a pause
to ensure adequate time for the slow visceral sensation to
be registered before participants rated their desire to void
sensation (sensation of fullness) on a 11-point scale with 0
being no desire to void and 10 having the strong desire to
void. Subjects rated the intensity of their feelings by the use
of a custom-built MR-compatible handheld optical response
system that we developed before [34], [35]. The response box
was held in the dominant right hand and included an analog
input device (i.e., a scrolling wheel or knob), which was set
to traverse the entire rating range with minimal thumb/index
finger twisting. The visual feedback consisted of a 11-point
visual analog scale (VAS) that was projected via an LCD
projector onto a translucent screen that stood at the foot of
the gantry of theMRI scanner. The subjects viewed the screen
from inside the scanner through a mounted mirror attached to
the head coil positioned above their eyes at a 45◦ angle. Prior
to the fMRI scan, subjects were catheterized transurethrally
with a silicone catheter (CH/FR 14, UROMED Kurt Drews
GmbH, Germany). After the initial intravesical filling with
100mL saline, the catheter was attached to the fluidic visceral
stimulation device and the fMRI scan begun with initial sub-
ject rating (10 seconds) followed by a 20-second initial rest
before automated intravesical filling and subsequent saline
withdrawal was initiated using the MR-compatible fluidic
visceral stimulation device. A precise synchronization of the
stimulus delivery with fMRI slice acquisition was achieved
by the detection of the 5V TTL trigger signals generated
by the 3T MRI scanner at each radiofrequency excitation
pulse. The imaging data were acquired on the same MRI
scanner (3T Ingenia, Philips Medical Systems) using the
same scanning parameters that we used forMR-compatibility
tests.
Imaging data were preprocessed using Statistical Para-
metric Mapping software (SPM12; Wellcome Department
of Cognitive Neurology, UK). The functional images were
realigned to correct for head movements, co-registered to
the T1 anatomical images, and normalized into the Mon-
treal Neurological Institute (MNI) stereotaxic coordinates
system using the EPI template provided with SPM12, and
smoothed with a Gaussian profile filter of full-width-half
maximum of 8 mm. The fMRI data were analyzed using
a general linear model (GLM) approach with the standard
hemodynamic response function [36]. Signal intensity time
course for each voxel was linearly determined to model two
task design-related regressors (i.e., intravesical saline infu-
sion, and intravesical saline drainage) and two regressors of
no-interest (i.e., subject ratings after intravesical infusion,
and subject ratings after intravesical drainage) by convolving
corresponding fMRI time-series with the canonical hemo-
dynamic response function. For the main effect, statistical
parametric maps of the t-statistic (SPM[t]) reflecting the
BOLD signal change were calculated for the visceral stimu-
lation (i.e., intravesical saline infusion) versus rest (p < 0.05
corrected for multiple comparisons using the family-wise
error (FWE), correction for the whole brain). Activationmaps
were overlaid on a high-resolution structural image in the
MNI orientation (supplied with SPM12 software package).
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TABLE 2. Image Quality Metrics for the Device MR-Compatibility Tests
With a Phantom.
FIGURE 7. Quantitative and qualitative assessments of the device
MR-compatibility. (a) Percent static SNR loss, and (b) Percent tSNR loss
for functional images acquired under four different experimental
conditions: without the presence of the device’s slave module in the MRI
scanner room (‘‘Baseline’’), with the slave module installed in the MRI
scanner room but powered off (‘‘Installed’’), with the installed and
powered on slave module (‘‘Powered’’), and with the installed, powered
on, and actuated slave module (‘‘Actuated’’); (c) (Top) a graphical
representation of phantom image for each testing condition. Middle slice
(slice number 17/34) is shown here; (Bottom) image subtraction results.
TABLE 3. Flow Rate Measurements Inside 3T MRI Scanner Room
III. RESULTS
A. DEVICE MR-COMPATIBILITY
The image quality metrics from different phantom test con-
ditions and imaging modalities are summarized in Table 2.
For none of the phantom condition, either the introduction of
TABLE 4. Volume delivery measurements inside 3T MRI scanner room.
FIGURE 8. Sample infusion and drainage profiles obtained inside the 3T
MRI scanner room while the scanner was running. Five different system
flow rates (i.e., 100 mL/min, 200 mL/min, 300 mL/min, 400 mL/min, and
500 mL/min) were tested. In each plot, the smoother line corresponds to
signal outputs of the slave module optical sensor while the other was
recorded from the optical sensor tracking the floating styrofoam ball.
the slave module into the MRI environment or its powering
and actuation caused any noticeable systematic impact on
spatial or temporal image quality and homogeneity. During
fMRI, the overall SNR and tSNR values over all slices in
the MR phantom images decreased by no more than 3.5%
across all testing conditions (Figs. 7a and 7b). The maximum
degradation of the field homogeneity was less than 0.5%.
The small differences between conditions were within normal
expected variability range [37], and no statistical significant
reductions in SNR or tSNR were observed (p > 0.05).
The results of the qualitative functional image analysis by
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FIGURE 9. Brain areas activated by intravesical infusion produced by the
MR-compatible fluidic visceral stimulation device in two representative
subjects. (a) Subject 1 (right-handed healthy female, 47 years)
(b) Subject 2 (right-handed healthy female, 21 years); RI = right insula;
ACC = anterior cingulate cortex; RI/PFC = right anterior insula and/or
lateral prefrontal cortex; CB = cerebellum; R = right side. MNI
coordinates: x = 3; y = 18; z = 10. Color bar shows scale of Student’s
t-values.
image substation method are displayed in Fig. 7c. To relate
the results to the expected BOLD signal changes in the fMRI
experiments, the maximum deviation of the signal intensity
in the center of the phantom was determined and results
from the middle slice (slice number 17/34) are shown in
Fig. 7c. The slices from other sections of the phantom had
similar image quality in every condition. Visual inspection
of all images including the field maps, showed no noticeable
field deformations or radiofrequency interference associated
with the presence of an external device in the vicinity of the
3T MRI scanner. Considering that the slave module (which
is the only part of the device that is placed in the MRI
scanner room) where made entirely form the durable poly-
meric materials devoid of any metallic pieces, there was no
magnetic forces (i.e., no deflection angle) or device heating
were observed during phantom MRI.
B. DEVICE PERFORMANCE
There was no difference in system performance with a
catheter and with a tube present (p > 0.05). For clarity
and due to lack of space, we only report results of sys-
tem performance with a catheter. No differences in flow
rate and volume delivery were found among different flow
rates (p > 0.05); however, the accuracy and precision of
flow rate and delivered volumes were slightly higher for
slower flow rates. The average accuracy and precision for
system flow rate, and delivered volumes over all tested flow
rates were 99.68% and 99.27%, respectively. The measure-
ments for the infusion and drainage flow rates and volume
delivery performed inside the MRI scanner room are listed
in Tables 3 and 4, respectively. There was no statistically
significant difference between the measurements obtained
with the quiescent scanner and with the scanner running
(p > 0.05). Sample infusion and drainage profiles for differ-
ent test flow rates while the scanner was running are shown
in Fig. 8.
C. BOLD fMRI RESULTS
Imaging data from two healthy subjects were evaluated. For
each subject, a general linear model was applied to the time
course of the signal of each voxel. Individual statistical para-
metric maps for intravesical stimulation > rest contrast were
calculated (p < 0.05, FWE-corrected for multiple compar-
isons). Whole brain activation maps from these two represen-
tative subjects are shown in Fig. 9. Consistent with previous
publications [12], [21], standard GLM analysis revealed acti-
vation in the bilateral insula, the anterior and mid-cingulate
cortex, the lateral prefrontal cortex, and the thalamus. For
both subjects, insular activation is greater on the right. One
of the subjects (subject 1) also showed activations in the
brainstem and cerebellar areas. The mean ± SD of desire
to void subject rating values after intravesical infusion, and
after intravesical drainage were 2.01± 0.81, and 1.17± 1.02,
respectively. None of the subjects reported any pain during
the experiment.
IV. DISCUSSION AND CONCLUSION
A significant challenge in designing a device in direct contact
with the viscera of the human body is its control principle
and safety of operation. Using such a system in an MRI
setting adds to the challenge level and necessitates care-
ful thinking to select the appropriate principle of actuation.
In this paper, we presented a novel closed-system, electrohy-
drostatically driven, optical feedback-controlled fluidic vis-
ceral stimulation device that can be safely used for BOLD
fMRI studies investigating interoception of visceral organs.
It permits passive non-painful stimulation relevant for
research and clinical assessments of visceral organs in the
confines of the 3T magnet. All sections of the device that
are placed inside the MRI scanner room are entirely made
of durable polymeric materials, and no ferromagnetic parts
are present to interfere with image quality. Due to the merit
of the electrohydrostatic actuation in separating the two
actuated platforms through a hydrostatic transmission line,
the device is proved to be MR-compatible with negligi-
ble impact on MRI data quality (static SNR loss < 2.5%,
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and tSNR loss < 3.5%). To achieve consistent system
performance in relation to delivered fluid flow rate and vol-
ume, and for logistical safety reasons, we also implemented
a fiber optic sensing unit for the slave module and freely-
programmable (C++) hardware components. The custom
software synchronizes the system with the MRI scanner by
detecting the TTL trigger signals generated by the MRI scan-
ner, receives feedback signals from the fiber optic sensing
unit, and continuously monitors the critical system param-
eters during fMRI. Accordingly, this device showed excel-
lent performance quality (flow rate and volume delivery
accuracy > 99%).
The utility of this device to deliver visceral stimulation
to internal organs in supine position during an actual fMRI
experiment was tested in two healthy volunteers. By deliv-
ering the fluid directly into a visceral organ (here, the blad-
der was used as an example) at a pre-defined intensity
(i.e., flow rate and volume), which was not perceptible to sub-
jects (as shown by persistent low urgency sensation even after
intravesical infusion of 90 mL saline), we were able to iden-
tify precisely those temporospatial responses attributable to
brain-viscera signaling pathway. By contrasting BOLD sig-
nals during the visceral stimulation with rest using GLMwith
the standard hemodynamic response function, we showed
that visceral interoception involves BOLD signal changes
in the bilateral insula, the anterior and mid-cingulate cor-
tex, the lateral prefrontal cortex, and thalamus. The prelim-
inary brain activation results from these subjects using the
proposed MR-compatible, MR-synchronized fluidic visceral
stimulation device are also in general agreement with our
previous fMRI studies using manual intravesical stimula-
tion [21], [38] and confirms the effectivity of the visceral
stimulus.
The proposed device is not only relevant for the study of
brain functions in healthy volunteers, but also for the study
of functional changes in the brain in neurological visceral
pathologies such as the dysfunctions of the lower urinary
tract and gastrointestinal tract for which distortions of both
top-down modulation of urogenital and gastrointestinal func-
tions, and bottom-up signaling from visceral afferents to the
brain have been reported by early investigators (see [39] and
also [40] for a comprehensive review). Both the lower urinary
and gastrointestinal tract dysfunctions are highly prevalent,
causing an enormous economic burden for every health care
system and also significantly impair quality of life of the
affected patients [41], [42]. Functional neuroimaging studies
are an extremely valuable tool to non-invasively investigate
such dysfunction in humans. Although the anatomic loca-
tions of main brain regions during interoceptive processing
have been identified in animal models as well as healthy
subjects, the function of the supraspinal regions as an inte-
grated system and its abnormality in the various visceral
dysfunctions are less well understood. Potential use of the
proposed MR-compatible fluidic visceral stimulation device
extends beyond established stimulation protocols and pro-
vides increased flexibility for designing new fMRI tasks
for different visceral organs that can be stimulated with the
fluidic-based methods. For example, the device could be
used for stimulating the gastrointestinal tract by the attach-
ment of a naso/orogastric tube similar to the catheter. The
alternative approaches to our proposed device are to either
have a urologist or gastroenterologist manually perform the
organ stimulation during an fMRI experiment or use mental
rehearsal or a pharmaceutical drug (e.g., diuretics) to emulate
the function of these organs. Performing manual infusion
and drainage can be challenging, time-consuming, and prone
to human error. Commercially available urodynamic devices
that are used during routine filling cystometry in urological
departments are neither MR-compatible nor strong enough
to provide the required filling speed (e.g., 300-400 mL/min)
for fMRI measurements. Other infusion systems that are used
in clinical research are notably limited in the programma-
bility of their infusion sequence and none are completely
MR-synchronizable. In comparison, our device is specifically
built for function inside the MRI environment and its param-
eters including flow rate and timing are monitored by an
MR-compatible sensing unit and can be synchronized with
TTL signals from the MRI scanner and adjusted using freely-
programmable software based on the experimenters exact
requirements.
From an engineering point of view there are two limita-
tions to the current device that can be improved in the next
generation of this device. The current configuration of the
device can only infuse one type of liquid at a time and lacks
the feature for infusing more than one fluid simultaneously
or one immediately after another. The current device also
lacks a fluid reservoir for refilling during the experiment.
Although this device was primarily designed to deliver a
maximum fluid volume of 100 mL, larger volumes may be
used for visceral stimulation. For example, during intragastric
infusion, the dispensed fluid is continuously infused to the
stomach over an extended time period and may need to be
replenished depending on the stimulation protocol and/or size
of the organ. One way to overcome this limit is by using
a bigger syringe. The infusion unit of the device can easily
accommodate different-size syringes and has an adjustable
clamp for securing a syringe of various diameters. However,
bigger syringes are usually expensive and not disposable.
An alternative is to use a refilling unit or reservoir with the
syringe in the infusion unit. Still, a number of issues need
to be addressed to ensure the system performance is not
compromised with the addition of a reservoir. First, fluid
from the reservoir needs to be degassed before injection
into the syringe to avoid, e.g., changes in flow rate due to
air bubbles. Second, an effective, MR-compatible method
needs to be developed for aspiration or refilling of a syringe
without requiring concurrent manipulation of a syringe
plunger.
In recent years there has been a promising literature on
imaging visceral sensations that has not been associated
with the traditional neuroimaging studies of interoception
(e.g., pain), but can be integrated easily, generating a broader
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perspective of neural correlates of interoception. Although
we are beginning to understand how the brain processes
afferent information from the viscera and internal organs,
clearly much research is still required to understand how such
interoceptive information is brought to the realm of conscious
perception and manifests its influence on our behavior. The
use of the automated MR-compatible, MR-synchronized flu-
idic visceral stimulation devices such as the one we have
presented in this paper, can provide increased flexibility for
designing and performing visceral stimulation tasks during
neuroimaging experiments; hence facilitate our understand-
ing of the brain networks that process interoception.
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